Chemo-enzymatic Total Synthesis and Combinatorial Biosynthesis of Maculalactones Enables Discovery of Anticancer Agents
Open Access
- 13 July 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Catalysis
- Vol. 16 (15) , 14450-14461
Abstract
Maculalactones are bioactive γ-butyrolactone natural products with promising antifouling properties, yet their limited availability constrains further development. Here, we report the characterization of the key biosynthetic enzymes MacE and MacF from the maculalactone (mac) biosynthetic gene cluster in Nodularia sp. NIES-3585. Exploiting the substrate flexibility of these biocatalysts, we developed a one-pot chemo-enzymatic platform that enabled the synthesis of 13 maculalactone derivatives in isolated yields of up to 96%. Furthermore, a plug-and-play combinatorial biosynthesis strategy with predictable product outcomes was established by assembling an artificial biosynthetic gene cluster from three distinct pathways, enabling the biosynthesis of previously inaccessible maculalactone analogs, including indole-containing derivatives, in a heterologous host (E. coli). Biological evaluation reveals that maculalactone derivatives exhibit cancer-type selective cytotoxicity, with several compounds displaying potent cytotoxicity against colorectal cancer cells (HCT116) with the best IC50 values reaching 2.7 μM. In contrast, only moderate or negligible activity was observed against lung and breast cancer cell lines, indicating pronounced selectivity. Initial mechanistic studies show that these compounds induce DNA damage, leading to apoptosis and inhibition of cancer cell proliferation. In addition, several derivatives exhibited antibacterial activity against Gram-positive pathogens, including Streptococcus pneumoniae. Collectively, our work establishes a general and programmable strategy for maculalactone diversification, expands their chemical and biological space, and highlights their potential as a promising scaffold for the development of selective anticancer agents.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (INST 269/973-1)
- China Scholarship Council
- Ministry of Finance and Science Saarland
This publication has 45 references indexed in Scilit:
- Expanding Polycyclic Tetramate Macrolactam (PoTeM) Core Structure Diversity by Chemo‐Enzymatic Synthesis and BioengineeringAngewandte Chemie International Edition, 2025
- Deciphering Chemical Mediators Regulating Specialized Metabolism in a Symbiotic CyanobacteriumAngewandte Chemie International Edition, 2022
- Emerging Enzymes for ATP Regeneration in Biocatalytic ProcessesChemBioChem, 2015
- Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic LeukemiaJAMA, 2011
- In vitro antifungal activity of indirubin isolated from a South Indian ethnomedicinal plant Wrightia tinctoria R. Br.Journal of Ethnopharmacology, 2010
- Synthesis of naturally occurring bioactive butyrolactones: maculalactones A–C and nostoclide ITetrahedron, 2005
- Total synthesis of (±) maculalactone A, maculalactone B and maculalactone C and the determination of the absolute configuration of natural (+) maculalactone A by asymmetric synthesisTetrahedron, 2004
- Chemistry and biology of maculalactone A from the marine cyanobacterium Kyrtuthrix maculansPhytochemistry Reviews, 2004
- Regeneration of cofactors for use in biocatalysisCurrent Opinion in Biotechnology, 2003
- Nostoclide I and II, extracellular metabolites from a symbiotic cyanobacterium, Nostoc sp., from the lichen Peltigera canina.Tetrahedron Letters, 1993